beta

GTXI

GTx Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

GTx Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of small molecules for treatment of cancer, including treatments for breast and prostate cancer and other medical conditions.

Market Cap: 254 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.gtxinc.com

Shares Outstanding: 21.5 Million

Float: 9.09 Million

Dividend: 0.0 (0.0%)

Beta: 1.574141

Sector: Healthcare

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1524 trading days

From: 2013-06-18 To: 2019-06-07

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2016-12-06 10.0 1.0 10.0
Data provided by IEX Cloud